Performance comparison of a co-crystal of carbamazepine with marketed product.
暂无分享,去创建一个
Orn Almarsson | Matthew L Peterson | Michael J Zaworotko | Magali B Hickey | M. Peterson | O. Almarsson | M. Zaworotko | Héctor R Guzmán | Mark D. Tawa | Zhong Zhang | J. Remenar | Magali B. Hickey | Julius F Remenar | Zhong Zhang | Lisa A Scoppettuolo | Sherry L Morrisette | Anna Vetter | Hector Guzmán | Mark D Tawa | Sean Haley | Anna M Vetter | Sean L. Haley | L. Scoppettuolo | Hector Guzmán
[1] Michael J. Zaworotko,et al. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2004 .
[2] Jeanette T. Dunlap,et al. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. , 2004, Journal of the American Chemical Society.
[3] W. Tong,et al. Impact of solid state properties on developability assessment of drug candidates. , 2004, Advanced drug delivery reviews.
[4] William Jones,et al. Solvent-drop grinding: green polymorph control of cocrystallisation. , 2004, Chemical communications.
[5] S. Itai,et al. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. , 2000, International journal of pharmaceutics.
[6] Michael Zschiesche,et al. Carbamazepine regulates intestinal P‐glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans , 2004, Clinical pharmacology and therapeutics.
[7] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[8] Aeri Park,et al. Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.
[9] W. Jones,et al. Crystal Engineering of Organic Cocrystals by the Solid-State Grinding Approach , 2005 .
[10] N. Bodor,et al. Oral pharmacokinetics of carbamazepine in dogs from commercial tablets and a cyclodextrin complex. , 1993, Journal of pharmaceutical sciences.
[11] W. Curatolo,et al. Drug polymorphism and dosage form design: a practical perspective. , 2004, Advanced drug delivery reviews.
[12] A. Matzger,et al. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. , 2003, Journal of pharmaceutical sciences.
[13] H. Brittain. Fluorescence studies of the transformation of carbamazepine anhydrate form III to its dihydrate phase. , 2004, Journal of pharmaceutical sciences.
[14] N. Rodríguez-Hornedo,et al. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph. , 2004, Journal of pharmaceutical sciences.
[15] D. Grant,et al. Polymorph screening: influence of solvents on the rate of solvent-mediated polymorphic transformation. , 2001, Journal of pharmaceutical sciences.
[16] Naír Rodríguez-Hornedo,et al. Cocrystal Formation during Cogrinding and Storage is Mediated by Amorphous Phase , 2006, Pharmaceutical Research.
[17] J. McMahon,et al. Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.
[18] N. Rodríguez-Hornedo,et al. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. , 2002, International journal of pharmaceutics.
[19] M. Eadie,et al. Dose-dependent metabolism of carbamazepine in humans , 1996, Epilepsy Research.
[20] Vinod P. Shah,et al. The Bioinequivalence of Carbamazepine Tablets with a History of Clinical Failures , 1992, Pharmaceutical Research.
[21] T. Tomson,et al. Clinical Pharmacokinetics and Pharmacological Effects of Carbamazepine and Carbamazepine-10,11-Epoxide , 1986 .
[22] Matt Peterson,et al. Application of high throughput technologies to drug substance and drug product development , 2004, Comput. Chem. Eng..
[23] Orn Almarsson,et al. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.
[24] L. Lesko,et al. The Relative Bioavailability and In Vivo-In Vitro Correlations for Four Marketed Carbamazepine Tablets , 1998, Pharmaceutical Research.